BMJ to require clinical trial data be made available
I’ve been following with interest the British Medical Journal‘s bold new move to refuse to publish research on drugs unless the clinical trial data is made available for independent analysis from January 2013. This is great news for other researchers, scientists and statisticians wanting to independently analyse and verify findings from studies.
In an editorial, the journal says they want to “leverage their power and publish only where there is a commitment to make the relevant anonymised patient level data available on reasonable request.” Further, they are campaigning for open data using Tamiflu as an important case study after being frustrated with years of trying to get drug company Roche to fulfill its promise to release full clinical trial results.
The BMJ quotes Ben Goldacre’s new book Bad Pharma:
“Drug companies around the world have produced some of the most amazing innovations of the past fifty years, saving lives on an epic scale. But that does not allow them to hide data, mislead doctors, and harm patients.”
Goldacre is one of a group of campaigners in the UK currently pushing the government to legislate for true transparency regarding clinical trials.
Watch a recent TED video from Ben Goldacre on the other “scandalous” problem of unreported trials of negative or inconclusive drug trial findings:
I believe Media Watch will be covering this story this weekend too.
Ben’s blog, Bad Science is always excellent reading, and I am looking forward to reading his newest book and hope that the BMJ’s campaign is successful.


